Literature DB >> 11129645

Leukocyte antimicrobial peptides: multifunctional effector molecules of innate immunity.

A Risso1.   

Abstract

Antimicrobial peptides are effector molecules of innate immunity that provide a first line of defense against pathogens. In mammals, they are stored in granules of leukocytes and are present in those sites that are exposed to microbial invasion, such as mucosal surfaces and skin. In the last decade, biochemical investigations and recombinant DNA technology have allowed the identification and characterization of several antimicrobial peptides from various animal and vegetal species. Most of the mammalian peptides have been grouped in two broad families: defensins and cathelicidin-derived peptides. Functional studies have shown that the toxicity mechanisms for many peptides consist of a rapid permeabilization of the target cell membrane. In addition to their microbicidal activity, some members of both families are multifunctional molecules, playing a modulating role in the inflammation and the antigen-driven immune response.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11129645

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  43 in total

1.  An Update on Vaginal Microbicides.

Authors:  Christine Mauck; Gustavo Doncel
Journal:  Curr Infect Dis Rep       Date:  2001-12       Impact factor: 3.725

2.  BMAP-28, an antibiotic peptide of innate immunity, induces cell death through opening of the mitochondrial permeability transition pore.

Authors:  Angela Risso; Enrico Braidot; Maria Concetta Sordano; Angelo Vianello; Francesco Macrì; Barbara Skerlavaj; Margherita Zanetti; Renato Gennaro; Paolo Bernardi
Journal:  Mol Cell Biol       Date:  2002-03       Impact factor: 4.272

Review 3.  Mammalian antibiotic peptides.

Authors:  P Síma; I Trebichavský; K Sigler
Journal:  Folia Microbiol (Praha)       Date:  2003       Impact factor: 2.099

4.  Vitamin d deficiency reduces the immune response, phagocytosis rate, and intracellular killing rate of microglial cells.

Authors:  Marija Djukic; Marie Luise Onken; Sandra Schütze; Sandra Redlich; Alexander Götz; Uwe-Karsten Hanisch; Thomas Bertsch; Sandra Ribes; Andrea Hanenberg; Simon Schneider; Cornelius Bollheimer; Cornel Sieber; Roland Nau
Journal:  Infect Immun       Date:  2014-03-31       Impact factor: 3.441

5.  A Low-Molecular-Weight Compound Derived from Human Leukocytes Determines a Bactericidal Activity of the Interferon Preparation.

Authors:  A S Vasilchenko; V A Gritsenko; D B Kosyan; E A Rogozhin
Journal:  Probiotics Antimicrob Proteins       Date:  2019-09       Impact factor: 4.609

6.  Determination of the antibacterial and lipopolysaccharide-neutralizing regions of guinea pig neutrophil cathelicidin peptide CAP11.

Authors:  Daiju Okuda; Shin Yomogida; Hiroshi Tamura; Isao Nagaoka
Journal:  Antimicrob Agents Chemother       Date:  2006-08       Impact factor: 5.191

Review 7.  Murine Models of Sepsis and Trauma: Can We Bridge the Gap?

Authors:  Julie A Stortz; Steven L Raymond; Juan C Mira; Lyle L Moldawer; Alicia M Mohr; Philip A Efron
Journal:  ILAR J       Date:  2017-07-01

8.  Augmentation of the lipopolysaccharide-neutralizing activities of human cathelicidin CAP18/LL-37-derived antimicrobial peptides by replacement with hydrophobic and cationic amino acid residues.

Authors:  Isao Nagaoka; Satoko Hirota; François Niyonsaba; Michimasa Hirata; Yoshiyuki Adachi; Hiroshi Tamura; Shigenori Tanaka; Didier Heumann
Journal:  Clin Diagn Lab Immunol       Date:  2002-09

9.  Heterotrimeric GAIT complex drives transcript-selective translation inhibition in murine macrophages.

Authors:  Abul Arif; Piyali Chatterjee; Robyn A Moodt; Paul L Fox
Journal:  Mol Cell Biol       Date:  2012-10-15       Impact factor: 4.272

10.  Killing of trypanosomatid parasites by a modified bovine host defense peptide, BMAP-18.

Authors:  Lee R Haines; Jamie M Thomas; Angela M Jackson; Brett A Eyford; Morteza Razavi; Cristalle N Watson; Brent Gowen; Robert E W Hancock; Terry W Pearson
Journal:  PLoS Negl Trop Dis       Date:  2009-02-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.